Thanks for sharing the article. I couldn’t open the original link, but I found it on the AFR.
The commentary was positive. She mentioned Bubs is in a strong position right now. US FDA approval is progressing, well and with about half of Bubs’ revenue coming from the US, that’s a major tailwind for growth.
It’s disappointing she didn’t mention China growth (it’s now half of US revenues) or the recent win against alpha group which $26M was awarded to bubs.
Hopefully, the silence is due to regulatory constraints and a formal market update is on the way
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $151.8M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.0¢ | $186.7K | 1.095M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2382753 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 1174514 | 17 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| BUB (ASX) Chart |